Related references
Note: Only part of the references are listed.Radiosynthesis and evaluation of novel [99mTc(I)]+ and [99mTc(I)(CO)3]+ complexes with a 4-nitroimidazole isocyanide for imaging tumor hypoxia
Qing Ruan et al.
APPLIED ORGANOMETALLIC CHEMISTRY (2020)
5-HT7 Receptor Contributes to Proliferation, Migration and Invasion in NSCLC Cells
Xiaohui Du et al.
ONCOTARGETS AND THERAPY (2020)
Novel [99mTc]-Tricarbonyl-NOTA-Conjugated Lactam-Cyclized Alpha-MSH Peptide with Enhanced Melanoma Uptake and Reduced Renal Uptake
Zheng Qiao et al.
MOLECULAR PHARMACEUTICS (2020)
Synthesis and evaluation of novel technetium-99m-hydroxamamide complex based on imidazothiadiazole sulfonamide targeting carbonic anhydrase-IX for tumor imaging
Shimpei Iikuni et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Pharmacology and Therapeutic Potential of the 5-HT7 Receptor
Kevin M. Blattner et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Remarkable Brain Penetration of Cyclopentadienyl M(CO)3+ (M=99mTc, Re) Derivatives of Benzothiazole and Benzimidazole Paves the Way for Their Application as Diagnostic, with Single-Photon-Emission Computed Tomography (SPECT), and Therapeutic Agents for Alzheimer's Disease
Marina Sagnou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Development of the 99mTc-Hydroxamamide Complex as a Probe Targeting Carbonic Anhydrase IX
Shimpei Iikuni et al.
MOLECULAR PHARMACEUTICS (2019)
Synthesis, Radiolabeling, and in Vitro and in Vivo Evaluation of [18F]ENL30: A Potential PET Radiotracer for the 5-HT7 Receptor
Elina Tampio L'Estrade et al.
ACS OMEGA (2019)
Acetylated Benzothiazolone as Homobivalent SPECT Metallo-Radiopharmaceutical 99mTc-(6-AcBTZ)2DTPA: Design, Synthesis, and Preclinical Evaluation for Mapping 5-HT1A/7 Receptors
Preeti Jha et al.
ACS OMEGA (2019)
Evaluation of EGFR-TK Expression with a 99mTc-Labeled Complex Bearing Quinazoline Pharmacophore
Zhan Si et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2019)
Synthesis and biodistribution of 1-[2(-cyclopentadienyltricarbonyltechnetium-99m)-2-oxo-ethoxyphenyl]-1,2-di- (p-hydroxyphenyl)but-1-ene for tumor imaging
Tesnim Dallagi et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2019)
Thiosemicarbazonate complexes with affinity for amyloid-β fibers: synthesis, characterization and biological studies
Arantxa Pino-Cuevas et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Evaluation of [18F]2FP3 in pigs and non-human primates
Hanne D. Hansen et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2019)
Radiation dosimetry of [131I]ICF01012 in rabbits: Application to targeted radionuclide therapy for human melanoma treatment
Elodie Jouberton et al.
MEDICAL PHYSICS (2018)
Design, physico-chemical and pre-clinical evaluation of a homo-bivalent Tc-99m-(BTZ)(2)DTPA radioligand for targeting dimeric 5-HT1A/5-HT7 receptors
Preeti Jha et al.
NEW JOURNAL OF CHEMISTRY (2018)
Evaluation of 5-HT7 Receptor Trafficking on In Vivo and In Vitro Model of Lipopolysaccharide (LPS)-Induced Inflammatory Cell Injury in Rats and LPS-Treated A549 Cells
Gulsen Ayaz et al.
BIOCHEMICAL GENETICS (2017)
Overcoming therapeutic resistance in glioblastoma: the way forward
Satoru Osuka et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives
Wojciech Szopa et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Radiosynthesis and evaluation of IGF1R PET ligand [11C]GSK1838705A
Kiran Kumar Solingapuram Sai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
5-Hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing β-catenin
Sarwat Fatima et al.
MOLECULAR ONCOLOGY (2016)
Small Molecules for Active Targeting in Cancer
Chin S. Kue et al.
MEDICINAL RESEARCH REVIEWS (2016)
Tryptophan hydroxylase 1 and 5-HT7 receptor preferentially expressed in triple-negative breast cancer promote cancer progression through autocrine serotonin signaling
Jaya Gautam et al.
MOLECULAR CANCER (2016)
Labeling and preliminary in vivo evaluation of the 5-HT7 receptor selective agonist [11C]E-55888
Hanne D. Hansen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Serotonin and Cancer: What Is the Link?
D. Sarrouilhe et al.
CURRENT MOLECULAR MEDICINE (2015)
Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies
Irina Kufareva et al.
IMMUNOLOGY AND CELL BIOLOGY (2015)
Evaluation of 3-Ethyl-3-(phenylpiperazinylbutyl)oxindoles as PET Ligands for the Serotonin 5-HT7 Receptor: Synthesis, Pharmacology, Radio labeling, and in Vivo Brain Imaging in Pigs
Matthias M. Herth et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Prognostic Significance of Dynamic 18F-FET PET in Newly Diagnosed Astrocytic High-Grade Glioma
Nathalie L. Jansen et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Synthesis, radiolabeling and in vivo evaluation of [11C](R)-1-[4-[2-(4-methoxyphenyl)phenyl piperazin-1-yl]-3-(2-pyrazinyloxy)-2-propanol, a potential PET radioligand for the 5-HT7 receptor
Hanne D. Hansen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Synthesis and pharmacological evaluation of a new series of radiolabeled ligands for 5-HT7 receptor PET neuroimaging
Julie Colomb et al.
NUCLEAR MEDICINE AND BIOLOGY (2014)
Diagnostic Performance of 18F-FET PET in Newly Diagnosed Cerebral Lesions Suggestive of Glioma
Marion Rapp et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma
Markus Hutterer et al.
NEURO-ONCOLOGY (2013)
A homodimeric bivalent radioligand derived from 1-(2-methoxyphenyl) piperazine with high affinity for in vivo 5-HT1A receptor imaging
Niraj Singh et al.
MEDCHEMCOMM (2012)
Glioblastoma Multiforme Imaging: The Role of Nuclear Medicine
George A. Alexiou et al.
CURRENT RADIOPHARMACEUTICALS (2012)
AN INTERINDIVIDUAL COMPARISON OF O-(2-[18F]FLUOROETHYL)-L-TYROSINE (FET)- AND L-[METHYL-11C]METHIONINE (MET)-PET IN PATIENTS WITH BRAIN GLIOMAS AND METASTASES
Anca-Ligia Grosu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Role of the 5-HT7 Receptor in the Central Nervous System: from Current Status to Future Perspectives
Anne Matthys et al.
MOLECULAR NEUROBIOLOGY (2011)
Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders
Marcello Leopoldo et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Synthesis of Specific SPECT-Radiopharmaceutical for Tumor Imaging Based on Methionine: 99mTc-DTPA-bis(methionine)
Puja Panwar Hazari et al.
BIOCONJUGATE CHEMISTRY (2010)
Correlation of MIB-1 staining index and 201Tl-SPECT retention index in preoperative evaluation of malignancy of brain tumors
Kenichiro Asano et al.
BRAIN TUMOR PATHOLOGY (2010)
Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines
R. E. Kast
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Ligand binding assays at equilibrium: validation and interpretation
Edward C. Hulme et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Efficient Tumor Targeting with High-Affinity Designed Ankyrin Repeat Proteins: Effects of Affinity and Molecular Size
Christian Zahnd et al.
CANCER RESEARCH (2010)
Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 Genes Involved in the Double-Strand Break Repair Pathway Predict Glioblastoma Survival
Yanhong Liu et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Correlation of glioma proliferation assessed by flow cytometry with 99mTc-Tetrofosmin SPELT uptake
George A. Alexiou et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2009)
A modeling analysis of the effects of molecular size and binding affinity on tumor targeting
Michael M. Schmidt et al.
MOLECULAR CANCER THERAPEUTICS (2009)
18F-FDG PET of common enhancing malignant brain tumors
Nobuyuki Kosaka et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2008)
Serotonin receptors
David E. Nichols et al.
CHEMICAL REVIEWS (2008)
Structural modifications of N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides:: Influence on lipophilicity and 5-HT7 receptor activity.: Part III
Marcello Leopoldo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Evaluation of glioma proliferation by 99mTc-Tetrofosmin
George A. Alexiou et al.
NEURO-ONCOLOGY (2008)
Structure -: Activity relationship study on N-(1,2,3,4-Tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents.: 2
Marcello Leopoldo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Serotonin via 5-HT7 receptors activates p38 mitogen-activated protein kinase and protein kinase C ε resulting in interleukin-6 synthesis in human U373 MG astrocytoma cells
K Lieb et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Single-photon agents for tumor imaging:: 201Tl, 99mTc-MIBI, and 99mTc-tetrofosmin
M Fukumoto
ANNALS OF NUCLEAR MEDICINE (2004)
Distribution of 5-HT7 receptors in the human brain:: a preliminary autoradiographic study using [3H]SB-269970
K Varnäs et al.
NEUROSCIENCE LETTERS (2004)
5-HT7 Receptors
David R. Thomas et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2004)
Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines
C Mahé et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Brain tumour imaging with PET:: a comparison between [18F]fluorodopa and [11C]methionine
A Becherer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Tc-99m MIBI uptake and its relation to the proliferative potential of brain tumors
L Ak et al.
CLINICAL NUCLEAR MEDICINE (2003)
Molecular, pharmacological and functional diversity of 5-HT receptors
D Hoyer et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Re tricarbonyl complexes with ligands containing P,N,N and P,N,O donor atom sets: Synthesis and structural characterization
JDG Correia et al.
INORGANIC CHEMISTRY (2001)
Correlation of thallium-201 uptake with proliferating cell nuclear antigen in brain tumours
F Gungor et al.
NUCLEAR MEDICINE COMMUNICATIONS (2000)
Share Paper
